8 videos that explain the tension between HIV activists and Big Pharma
From Hollywood blockbusters, to investigative documentaries, to our own short, satirical animation, here are eight videos that show how the...
Read more about 8 videos that explain the tension between HIV activists and Big Pharma
Fixing the broken patent system: From Marrakech and back again
Marrakech was home to the signing of the TRIPS Agreement in 1995, an agreement that has been exploited by pharmaceutical...
Read more about Fixing the broken patent system: From Marrakech and back again
Storify: Pathways to Access #GSIPA2M
[View the story “Pathways to Access! #GSIPA2M (15-17 Jan 2018)” on Storify] SaveSave
Read more about Storify: Pathways to Access #GSIPA2M
-
GSIPA2M: The Summit Highlights
Catch up on the activity from our inaugural Global Summit on Intellectual Property and Access to Medicines (15-17 January 2018)....
Read more about GSIPA2M: The Summit Highlights
GSIPA2M: Malaysia Ministry of Health 2018 winner of the Leadership Award on Intellectual Property and Access to Medicines
Malaysia’s “historic decision” to issue a compulsory license on Hep C medicine, sofosbuvir, stands up to Big Pharma, and will mean...
Read more about GSIPA2M: Malaysia Ministry of Health 2018 winner of the Leadership Award on Intellectual Property and Access to Medicines
Malaysia paves the way for compulsory licensing on hepatitis C medicines
Historic decision will cure more hepatitis C patients – and other countries can follow suit. Today, 20 September 2017, Malaysia’s...
Read more about Malaysia paves the way for compulsory licensing on hepatitis C medicines
Tackling the hepatitis C epidemic in Malaysia
With new, revolutionary, drugs available, why isn’t everyone getting the cure? An estimated 454,000 people are living with hepatitis C...
Read more about Tackling the hepatitis C epidemic in Malaysia